Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients
Up to 50% of all patients face an intermediate risk of developing CAD, and the optimal treatment strategy for that population remains unclear. For this study, researchers explored data from more than 400 intermediate-risk patients with a family history of premature CAD.
AI-powered risk model evaluates long-term risk of coronary artery disease
The advanced machine learning model tracks more than 50 different factors to make its predictions. It has already been found to be more accurate than popular prediction methods for heart disease that are currently available.
Tracking major trends and clinical research in acute coronary syndrome care
Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women
Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?

ACC, AHA release long-awaited chest pain guidelines

The new guidelines stress the importance of more complete chest pain evaluations, patient communication and shared decision-making.

Researchers, take note: Nonfatal MI not a surrogate for all-cause or cardiovascular mortality

The new study, published in JAMA Internal Medicine, examined data from 144 different randomized clinical trials.

Personalized clotting profiles could boost care for high-risk cardiac patients

The study, published in Blood Advances, suggests that a "one size fits all" approach to cardiac care could soon be a thing of the past.

Blood pressure targets may need to be personalized for each patient

“Our results suggest that BP targets may need to be modified depending on the CV outcome for which the patient is most at risk,” researchers said.

Functional iron deficiency an 'important risk factor' for CVD

The condition was also linked to all-cause mortality.

Task force: Aspirin not recommended to prevent first MI or stroke

Starting a daily aspirin regimen in people age 60 or older can cause potentially serious harm including internal bleeding, the USPSTF warned Tuesday.

New battery-powered device diagnoses heart attacks in just minutes

The portable sensor, developed by specialists at the University of Notre Dame and University of Florida, targets the patient's microRNA.

High cholesterol at a young age increases your risk of CHD later in life

Maintaining optimal levels of LDL-C during young adulthood and middle age is one way to limit the risk of coronary heart disease.

Acute Coronary Syndromes

Proactive CAD strategies fueled by calcium scores lead to benefits for intermediate-risk patients

AI-powered risk model evaluates long-term risk of coronary artery disease

Tracking major trends and clinical research in acute coronary syndrome care

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women